Integra Short Term Debt from 2010 to 2024
| IART Stock | USD 30.90 0.10 0.32% |
Short Term Debt | First Reported 1999-03-31 | Previous Quarter 29.8 M | Current Value 35.7 M | Quarterly Volatility 177.9 M |
Check Integra LifeSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integra main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.7 M, Interest Expense of 75.4 M or Total Revenue of 1.6 B, as well as many exotic indicators such as Price To Sales Ratio of 4.18, Dividend Yield of 3.0E-4 or PTB Ratio of 3.53. Integra financial statements analysis is a perfect complement when working with Integra LifeSciences Valuation or Volatility modules.
Integra | Short Term Debt |
Latest Integra LifeSciences' Short Term Debt Growth Pattern
Below is the plot of the Short Term Debt of Integra LifeSciences Holdings over the last few years. It is Integra LifeSciences' Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
| Short Term Debt | 10 Years Trend |
|
Short Term Debt |
| Timeline |
Integra Short Term Debt Regression Statistics
| Arithmetic Mean | 77,329,150 | |
| Geometric Mean | 18,776,018 | |
| Coefficient Of Variation | 216.80 | |
| Mean Deviation | 89,254,627 | |
| Median | 28,324,250 | |
| Standard Deviation | 167,650,987 | |
| Sample Variance | 28106.9T | |
| Range | 663.3M | |
| R-Value | 0.07 | |
| Mean Square Error | 30115.2T | |
| R-Squared | 0.01 | |
| Significance | 0.80 | |
| Slope | 2,671,338 | |
| Total Sum of Squares | 393495.9T |
Integra Short Term Debt History
About Integra LifeSciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Integra LifeSciences income statement, its balance sheet, and the statement of cash flows. Integra LifeSciences investors use historical funamental indicators, such as Integra LifeSciences's Short Term Debt, to determine how well the company is positioned to perform in the future. Although Integra LifeSciences investors may use each financial statement separately, they are all related. The changes in Integra LifeSciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Integra LifeSciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Integra LifeSciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Integra LifeSciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short Term Debt | 29.8 M | 28.3 M |
Pair Trading with Integra LifeSciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integra LifeSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integra LifeSciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Integra Stock
| 0.82 | AHG | Akso Health Group | PairCorr |
| 0.89 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
Moving against Integra Stock
| 0.82 | WGS | GeneDx Holdings Corp | PairCorr |
| 0.69 | GCTK | GlucoTrack | PairCorr |
| 0.6 | ESTA | Establishment Labs | PairCorr |
| 0.54 | INGN | Inogen Inc | PairCorr |
The ability to find closely correlated positions to Integra LifeSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integra LifeSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integra LifeSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integra LifeSciences Holdings to buy it.
The correlation of Integra LifeSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integra LifeSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integra LifeSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Integra LifeSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Integra LifeSciences Correlation against competitors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.51 | Revenue Per Share 19.349 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0383 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.